Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
bmiSMART is a consumer healthcare brand specializing in scientifically-backed weight management supplements. The company's product line includes I-remove, I-block, and I-control, which utilize patented complexes like Litramine to target fat binding, carbohydrate blocking, and appetite suppression. bmiSMART positions itself as a provider of smart weight loss solutions that are clinically proven and naturally sourced. The brand is part of the Zaluvida Group and operates primarily in the nutraceutical and over-the-counter healthcare markets. Its products are often classified as medical devices in certain jurisdictions due to their mechanical mode of action. The company focuses on delivering effective, non-pharmacological options for individuals seeking to manage their weight and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bmiSMART.